glp 1 court case Details of failed studies cast pall on Novo Nordisk's GLP-1 as Alzheimer's treatment FDA issued 25 warning letters

Long term liraglutide studies show similar patterns

It has also been shown to promote weight loss in certain patients, although that is not its intended use

[DOI] [PMC free article] [PubMed] [Google Scholar] 262.Bahour N, Cortez B, Pan H, Shah H, Doria A, Aguayo-Mazzucato C

GLP-1 receptor (GLP-1R) agonists control glycemia via glucose-dependent mechanisms of action and promote weight loss in obese and diabetic individuals

For consumer goods companies, this represents both a challenge and an opportunity

In this regard, high-quality studies are needed to provide definitive answers about who should suspend these drugs, for example, obese patients due to the fact of difficult intubation, and who should not, for example, type 2 diabetes mellitus for their cardiovascular, renal, and cerebral positive side effects